Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Chiara Pandolfo"'
Autor:
Francesca Maria Consonni, Barbara Durante, Marcello Manfredi, Augusto Bleve, Chiara Pandolfo, Valentina Garlatti, Virginia Vita Vanella, Emilio Marengo, Elettra Barberis, Barbara Bottazzi, Sara Bombace, Ilaria My, Gianluigi Condorelli, Valter Torri, Antonio Sica
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Even though cancer patients are generally considered more susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the mechanisms driving their predisposition to severe forms of coronavirus disease 2019 (COVID-19) have n
Externí odkaz:
https://doaj.org/article/cd79b754e270428c80b3122a228e5e7b
Autor:
Francesca Maria Consonni, Chiara Porta, Arianna Marino, Chiara Pandolfo, Silvia Mola, Augusto Bleve, Antonio Sica
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Myeloid-derived suppressor cells (MDSCs) represent a heterogeneous population of immature myeloid cells with major regulatory functions and rise during pathological conditions, including cancer, infections and autoimmune conditions. MDSC expansion is
Externí odkaz:
https://doaj.org/article/0ee969d39d2447d190527f35dc5640aa
Publikováno v:
Clinical Reviews in Allergy & Immunology
The immune system is the central regulator of tissue homeostasis, ensuring tissue regeneration and protection against both pathogens and the neoformation of cancer cells. Its proper functioning requires homeostatic properties, which are maintained by
Autor:
Paola Ferrazzi, Silvia Della Bella, Corrado Lodigiani, Paolo Uva, F. Calcaterra, Monica Bacci, Domenico Mavilio, Claudia Carenza, Chiara Pandolfo, Massimiliano Pagani
Publikováno v:
Cardiovascular Research. 116:698-707
Aims The pathogenetic mechanisms underlying unprovoked venous thromboembolism (uVTE) are largely unknown. In this study, we investigated the molecular mechanisms involved in uVTE pathogenesis by using ex vivo expanded endothelial colony-forming cells
Autor:
Paolo Kunderfranco, Andrea Doni, Giulia Grazia, Roberta Mortarini, Massimo Milione, Francesco Sgambelluri, Chiara Alì, Andrea Anichini, Alberto Termanini, Andrea Maurichi, Marco Fabbri, Mariangela Storto, Eliana Rulli, Laura Gribaldo, Chiara Pandolfo, Marco Erreni, Francesca Maria Consonni, Antonio Sica, Augusto Bleve, Mario Santinami, Maria Grazia Totaro, Valter Torri, Fabio Pasqualini, Miguel P. Soares
Publikováno v:
Nature immunology. 22(5)
Although the pathological significance of tumor-associated macrophage (TAM) heterogeneity is still poorly understood, TAM reprogramming is viewed as a promising anticancer therapy. Here we show that a distinct subset of TAMs (F4/80hiCD115hiC3aRhiCD88
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 21, Iss 6866, p 6866 (2020)
International Journal of Molecular Sciences, Vol 21, Iss 6866, p 6866 (2020)
Tumor-associated macrophages (TAMs) are the main population of myeloid cells infiltrating solid tumors and the pivotal orchestrators of cancer-promoting inflammation. However, due to their exceptional plasticity, macrophages can be also key effector